Back

CYP2C19-dependent clopidogrel resistance is a possible cause for coronary stent and peripheral bypass occlusion

25 August 2018 (11:00 - 16:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Antiplatelet and anticoagulant drugs Antiplatelet Drugs ESC Premium Access ESC Congress 2018

About the speaker

Photo
Associate Professor Milka Klinceva

Zan Mitrev Clinic, Skopje (North Macedonia)

5 More presentations in this session

Presentation thumbnail
Doctor T. Petroni (Montauban, FR)
Abstract
Presentation thumbnail
Mrs A. Kosinova (Elvas, PT)
Abstract Slides
Presentation thumbnail
Professor R. Rosenson (New York City, US)
Abstract Slides
Presentation thumbnail
Doctor A. Almaghraby (Ras Al Khaimah, AE)
Abstract Slides
Presentation thumbnail
Doctor J. Michel (Austin, US)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 1 - Antiplatelet and anticoagulant drugs

The Event

Event poster

ESC Congress 2018

25 August 2018 11:00 CET
You may be interested in
thumbnail
Webinar
Aspirin treatment for mitigating thrombotic risk across the cardiovascular risk continuum
thumbnail
Congress Presentation
Antithrombotic therapy in diabetes
thumbnail
Congress Session
State-of-the-art antithrombotic treatment in acute coronary syndromes: a paradigm shift?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources